MAPT and Alzheimer disease: It is hypothesized that in AD, soluble amyloid hyperphosphorylates tau, leading to disruption in microtubule dynamics, damaging of cellular axonal transport, and a decrease in proteasome activity (Iqbal et al., 2009; Wang et al., 2013).